SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Roader who wrote (688)4/18/1997 9:24:00 AM
From: Doug Markle   of 1762
 
AND MORE SELLERS OUT THERE............

IDEC PHARMACEUTICALS
SHAREHOLDER FILES FORM 144, TO
SELL SHARES

Source: XINHUA

via SpyWire via Individual Inc. : a shareholder of IDEC
PharmaceuticalsCorp. of San Diego, Calif., reported the proposed
sale of 540,860 shares on March 21, 1997, for $13, 791,215
through Smith Barney. IDEC has 18,016,354 shares outstanding;
they trade OTC.

[04-17-97 at 16:13 EDT, Copyright 1997, Comtex]
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News